WHO ICTRP trial
The effect of Buyang Huanwu Decoction on improving the cognitive impairment of…
ChiCTR2200055242 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200055242 |
|---|---|
| Public title | The effect of Buyang Huanwu Decoction on improving the cognitive impairment of diabetic encephalopathy and the molecular mechanism of protecting blood brain barrier |
| Scientific title | The effect of Buyang Huanwu Decoction on improving the cognitive impairment of diabetic encephalopathy and the molecular mechanism of protecting blood brain barrier |
| Primary sponsor | The First Hospital of Hebei Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Diabetic encephalopathy cognitive dysfunction |
| Interventions | Experimental group:Give patients Buyang Huanwu decoction;Control group:Give patients a placebo with no treatment effect patients placebo that had no therapeutic effect |
| Registration date | Jan 4, 2022 |
| Target size | Experimental group:40;Control group:40 |
| Secondary IDs | ChiMCTR2200005496 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: